Inhibrx Biosciences IncNASDAQ:INBX
- LAST PRICE14.3400
- TODAY'S CHANGE (%)-1.3600 (-8.6624%)
- Bid / Lots14.3300/ 3
- Ask / Lots14.3700/ 2
- Open / Previous Close15.6400 / 15.7000
- Day Range
- 52 Week Range
- Volume203,472
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INBX |
|---|---|---|
| 09:36 ET | 500 | 15.585 |
| 09:39 ET | 491 | 15.51 |
| 09:41 ET | 1600 | 15.62 |
| 09:43 ET | 300 | 15.49 |
| 09:45 ET | 838 | 15.4 |
| 09:48 ET | 200 | 15.4 |
| 09:50 ET | 326 | 15.26 |
| 09:52 ET | 5749 | 15.1 |
| 09:54 ET | 1221 | 15.13 |
| 09:56 ET | 463 | 15.23 |
| 09:57 ET | 4638 | 15.15 |
| 09:59 ET | 1646 | 15 |
| 10:01 ET | 2550 | 14.91 |
| 10:03 ET | 1650 | 14.86 |
| 10:06 ET | 851 | 14.77 |
| 10:08 ET | 3702 | 14.835 |
| 10:10 ET | 3204 | 14.78 |
| 10:12 ET | 600 | 15.01 |
| 10:14 ET | 5806 | 14.835 |
| 10:15 ET | 4208 | 14.8125 |
| 10:17 ET | 15989 | 14.83 |
| 10:19 ET | 500 | 14.89 |
| 10:21 ET | 4918 | 14.92 |
| 10:24 ET | 1300 | 15.01 |
| 10:26 ET | 605 | 15.07 |
| 10:28 ET | 417 | 15.07 |
| 10:32 ET | 300 | 14.935 |
| 10:33 ET | 598 | 15.07 |
| 10:35 ET | 406 | 14.935 |
| 10:37 ET | 200 | 14.9 |
| 10:39 ET | 971 | 14.995 |
| 10:42 ET | 501 | 15 |
| 10:44 ET | 567 | 14.985 |
| 10:48 ET | 400 | 15.05 |
| 10:50 ET | 100 | 15 |
| 10:51 ET | 300 | 15 |
| 10:53 ET | 1400 | 15.01 |
| 10:55 ET | 3377 | 15 |
| 10:57 ET | 2861 | 15 |
| 11:00 ET | 200 | 15.03 |
| 11:02 ET | 285 | 15.05 |
| 11:04 ET | 896 | 15.04 |
| 11:08 ET | 100 | 14.99 |
| 11:09 ET | 300 | 14.98 |
| 11:11 ET | 100 | 14.92 |
| 11:13 ET | 409 | 14.815 |
| 11:15 ET | 200 | 14.81 |
| 11:18 ET | 512 | 14.82 |
| 11:20 ET | 1031 | 14.815 |
| 11:22 ET | 1995 | 14.85 |
| 11:24 ET | 400 | 14.88 |
| 11:26 ET | 1592 | 14.845 |
| 11:27 ET | 1208 | 14.77 |
| 11:29 ET | 100 | 14.75 |
| 11:31 ET | 100 | 14.77 |
| 11:33 ET | 300 | 14.77 |
| 11:36 ET | 2903 | 14.64 |
| 11:38 ET | 100 | 14.66 |
| 11:40 ET | 607 | 14.75 |
| 11:42 ET | 300 | 14.66 |
| 11:44 ET | 800 | 14.605 |
| 11:45 ET | 237 | 14.57 |
| 11:47 ET | 300 | 14.55 |
| 11:49 ET | 700 | 14.56 |
| 11:51 ET | 2525 | 14.39 |
| 11:54 ET | 700 | 14.445 |
| 11:56 ET | 1099 | 14.27 |
| 11:58 ET | 523 | 14.25 |
| 12:00 ET | 200 | 14.23 |
| 12:02 ET | 4456 | 14.105 |
| 12:03 ET | 1226 | 14.09 |
| 12:05 ET | 3600 | 14.08 |
| 12:12 ET | 607 | 14.09 |
| 12:14 ET | 100 | 14.08 |
| 12:16 ET | 300 | 14.08 |
| 12:18 ET | 850 | 14.0001 |
| 12:20 ET | 400 | 13.935 |
| 12:23 ET | 800 | 13.99 |
| 12:25 ET | 5852 | 14.01 |
| 12:27 ET | 326 | 13.97 |
| 12:30 ET | 300 | 13.93 |
| 12:32 ET | 500 | 14.005 |
| 12:34 ET | 400 | 13.98 |
| 12:36 ET | 200 | 14.015 |
| 12:38 ET | 800 | 13.96 |
| 12:39 ET | 4362 | 14.01 |
| 12:43 ET | 2517 | 14.01 |
| 12:45 ET | 300 | 14 |
| 12:48 ET | 2321 | 14.06 |
| 12:50 ET | 100 | 14.08 |
| 12:54 ET | 300 | 14.17 |
| 12:56 ET | 200 | 14.095 |
| 12:57 ET | 200 | 14.03 |
| 12:59 ET | 300 | 14.16 |
| 01:01 ET | 200 | 14.03 |
| 01:03 ET | 300 | 14.105 |
| 01:06 ET | 400 | 14.105 |
| 01:08 ET | 100 | 14.05 |
| 01:10 ET | 500 | 14.06 |
| 01:12 ET | 200 | 14.115 |
| 01:14 ET | 200 | 14.115 |
| 01:15 ET | 700 | 14.115 |
| 01:17 ET | 2769 | 14.15 |
| 01:19 ET | 100 | 14.13 |
| 01:21 ET | 200 | 14.13 |
| 01:24 ET | 400 | 14.16 |
| 01:26 ET | 500 | 14.15 |
| 01:28 ET | 2952 | 14.135 |
| 01:30 ET | 2589 | 14.13 |
| 01:32 ET | 646 | 14.13 |
| 01:33 ET | 800 | 14.12 |
| 01:35 ET | 4196 | 14.23 |
| 01:37 ET | 1000 | 14.2686 |
| 01:39 ET | 1889 | 14.27 |
| 01:42 ET | 740 | 14.27 |
| 01:44 ET | 846 | 14.35 |
| 01:48 ET | 500 | 14.4 |
| 01:51 ET | 440 | 14.43 |
| 01:53 ET | 300 | 14.31 |
| 01:57 ET | 200 | 14.32 |
| 02:00 ET | 2300 | 14.33 |
| 02:02 ET | 1174 | 14.34 |
| 02:04 ET | 200 | 14.34 |
May 30, 2024
*DJ News On Inhibrx Biosciences Inc. (INXBV) Now Under INXB, from 5:08PM ET on Thursday May 30, 2024 by Dow Jones
5:08PM ET on Thursday May 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Inhibrx Biosciences Inc | 227.3M | -2.7x | --- |
Q32 Bio Inc | 222.2M | -0.8x | --- |
ATAI Life Sciences NV | 229.3M | -5.6x | --- |
Inovio Pharmaceuticals Inc | 235.5M | -1.6x | --- |
Acrivon Therapeutics Inc | 223.9M | -2.5x | --- |
Ovid Therapeutics Inc | 233.4M | -1.4x | --- |
Company Information
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. The Company’s clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106. INBRX-109 is a tetravalent agonist of death receptor 5 (DR5) that is designed with its proprietary single domain antibody, or sdAb, platform to drive cancer-selective programmed cell death and to maximize potency while minimizing on-target liver toxicity arising from hepatocyte apoptosis. INBRX-106 is a hexavalent OX40 agonist, being investigated as a single agent and in combination with Keytruda, a PD-1 blocking checkpoint inhibitor, in patients with locally advanced or metastatic solid tumors. INBRX-106 is a precisely engineered hexavalent sdAb-based therapeutic candidate targeting OX40, designed to be an optimized agonist of this co-stimulatory receptor.
Contact Information
- Headquarters
- 11025 N. Torrey Pines Road, Suite 140LA JOLLA, CA, United States 92037
- Phone
- 858-795-4220
- Fax
- 302-636-5454
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $227.3M |
|---|---|
Revenue (TTM) | $1.8M |
Shares Outstanding | 14.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-5.35 |
Book Value | $0.92 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | 127.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,980.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
